Annual Compliance Verification Report for 2022-2023
Advocacy & Action
Final Assessment for Aldehydes Group Published
Another Update to the Nitrosamine Guidance Document
Health Canada Published 2023 Hotlist Amendments
Notice of intent to Amend the Domestic Substances List
Final Assessment and Canada Gazette Notice on SNAc Provisions for Piperazine
Report on Activities – Food and Drugs Act Liaison Office
Guidance Document on the Regulatory Requirements for Drug Identification Number
Draft Assessment for the Gas Oils and Kerosenes with Uses in Products Available to Consumers Group Published
NERBy GMP Evidence
